Heart Transplant Recipients Clinical Trial
High-intensity training (HIT) has repeatedly been documented to have superior positive
effects compared to moderate exercise in patients with coronary heart disease and heart
failure. Since heart transplant recipients (HTx), have a denervated heart with different
respond to exercise, HIT has previously not been introduced among these patients.
Rikshospitalet carried out a RCT to investigate this (the TEX study 2009-2012), and found
that this form of exercise also was highly effective and safe in long term HTx with
clinically significant improvement in VO2peak, muscular exercise capasity, general HRQoL,
and even slower progression of CAV (coronary allograft vasculopathy). Based on these
findings we ask the following questions in this follow-up study:
1. Would the effect on VO2peak, HRQoL,muscle capacity and CAV obtained during the study
period continue during long term follow up (5 years)?
2. Is the intervention group more physical active after HIT compared to the control group?
n/a
Observational Model: Case-Crossover, Time Perspective: Cross-Sectional
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02077764 -
The GRAFT Study: Evaluation of Graft Function, Rejection and Cardiac Allograft Vasculopathy in First Heart Transplant Recipients.
|
N/A | |
Terminated |
NCT01278745 -
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
|
Phase 2 | |
Recruiting |
NCT06190171 -
Respiratory Strength Training in Heart Transplant Recipients
|
N/A | |
Completed |
NCT01912248 -
Acute Effect of Strength Training on Blood Pressure in Cardiac Patients
|
N/A | |
Active, not recruiting |
NCT01759966 -
Autonomic Cardiovascular Control After Heart Transplantation
|
||
Completed |
NCT01914406 -
High-intensity Interval Training Versus Moderate Continuous Training in Heart Transplant Recipients.
|
N/A | |
Completed |
NCT01796379 -
High Intensity Training in de Novo Heart Transplant Recipients in Scandinavia
|
N/A | |
Completed |
NCT03662789 -
Intravenous Iron Supplement for Iron Deficiency in Cardiac Transplant Recipients
|
Phase 2/Phase 3 |